Dynamics of the microbiota in patients with Clostridioides difficile: Recurrence, treatment, sex, and immunosuppression
PLOS Pathogens · 2026
DOI: 10.1371/journal.ppat.1014063 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Maria Paz Ventero und 26 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Service, Alicante General University Hospital - Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain. Hauptthemen laut MEDLINE: Clostridium Infections, Clostridioides difficile, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana, Instituto de Investigacion Sanitaria y Biomédica de Alicante - ISABIAL.
Abstract (Originalsprache)
Background
Alterations in the gut microbiome are central to the pathogenesis and recurrence of Clostridioides difficile infection (CDI).
Objective
To evaluate intestinal microbiome changes during CDI and their association with recurrence, sex, age, and immunosuppression.
Methods
Patients from the CDI-ANCRAID-SEICV cohort were consecutively enrolled. Stool samples were obtained at diagnosis (Dx), end of treatment (ET), and eight weeks post-treatment (8W) or upon recurrence. Microbiota composition was analyzed by 16S rRNA sequencing using QIIME2 and R. Outcomes were compared by demographics, immunosuppression, and treatment (vancomycin [VNC], vancomycin-bezlotuzumab [VNC-BZL], fidaxomicin [FDX]).
Results
Among 143 patients, non-recurrent cases showed higher biodiversity at 8W versus diagnosis (H p = 0.002, ASVs p < 0.001), unlike recurrent cases. Diversity decreased with VNC (H p > 0.001, ASVs p < 0.001) but was preserved with FDX (H p = 0.15). Recovery of Shannon diversity was limited in women (p = 0.50) and immunocompromised patients (p = 0.31). At ET, Fusobacteria and Verrucomicrobiota were less abundant in recurrent than non-recurrent cases (0.77%, 0.53% vs 3.43%, 3.50%). FDX-treated samples showed higher Bacteroidetes (31.33%) compared to VNC (5.23%) or VNC-BZL (3.12%). Women exhibited increased Firmicutes abundance (p = 0.034).
Conclusions
Restoration of microbial diversity correlates with CDI resolution. FDX preserves gut microbiota better than VNC or VNC-BZL. Women and immunocompromised patients demonstrate impaired microbiota recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Microbiology Service, Alicante General University Hospital - Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain.
- Clinical Unit of Infectious Diseases and Microbiology, Valme University Hospital, Institute of Biomedicine of Seville (IBiS), University of Seville, Sevilla, Spain.
- Clinical Medicine Department, Miguel Hernández University, Elche, Spain.
- Unit of Infectious Diseases, Alicante General University Hospital - Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain.
- Unit of Infectious Diseases, Vega Baja University Hospital - Orihuela, Spain-FISABIO, Foundation for the Promotion of Health and Biomedical Research of the Valencian Community, Valencia, Spain.
- Unit of Infectious Diseases, Virgen Macarena University Hospital, Sevilla, Spain.
ORCID-Profile: Juan Carlos Rodríguez
Förderung
- Instituto de Salud Carlos III
- Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana
- Instituto de Investigacion Sanitaria y Biomédica de Alicante - ISABIAL
- Ministerio de Ciencia e Innovación
Zitieren
APA
Ventero, M. P., Herrero, R., Tyshkovska, I., Valverde-Fredet, M. D., Rodríguez, J. C., Rodríguez-Fernández, M., González-De-La-Aleja, P., Trigo, M., Parra, M., Aller, A. I., Otero, S., Espindola-Gomez, R., Ramos, J. M., León, E. M., García, M., Navarrete-Lorite, M. N., Llenas-García, J., Portillo, I., Jover, F., …, & De Lucas, E. M. (2026). Dynamics of the microbiota in patients with Clostridioides difficile: Recurrence, treatment, sex, and immunosuppression. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014063
Vancouver
Ventero MP, Herrero R, Tyshkovska I, Valverde-Fredet MD, Rodríguez JC, Rodríguez-Fernández M, et al. Dynamics of the microbiota in patients with Clostridioides difficile: Recurrence, treatment, sex, and immunosuppression. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014063
BibTeX
@article{Ventero2026,
author = {Ventero, Maria Paz and Herrero, Rocio and Tyshkovska, Iryna and Valverde-Fredet, Maria-Dolores and Rodríguez, Juan Carlos and Rodríguez-Fernández, Miguel and González-De-La-Aleja, Pilar and Trigo, Marta and Parra, Monica and Aller, Ana-Isabel and Otero, Silvia and Espindola-Gomez, Reinaldo and Ramos, José Manuel and León, Eva M and García, Maria and Navarrete-Lorite, Miguel Nicolas and Llenas-García, Jara and Portillo, Ines and Jover, Francisco and Tasias, Maria and Caston, Juan Jose and Gil, Concepción and Vinuesa-Garcia, David and Gomez-Ayerbe, Cristina and Martínez Marcos, Francisco J and Merchante, Nicolas and De Lucas, Esperanza Merino},
title = {Dynamics of the microbiota in patients with Clostridioides difficile: Recurrence, treatment, sex, and immunosuppression},
journal = {PLOS Pathogens},
year = {2026},
doi = {10.1371/journal.ppat.1014063}
}
EUVIMED